Autoimmune Disease Diagnostics Market by Type, Indication, Test, Product, End User

Description

List of Tables

[192 Pages Report] The Autoimmune Disease Diagnostics Market size was estimated at USD 5.08 billion in 2023 and expected to reach USD 5.53 billion in 2024, at a CAGR 9.06% to reach USD 9.33 billion by 2030.

Global Autoimmune Disease Diagnostics Market

KEY MARKET STATISTICS
Base Year [2023]	USD 5.08 billion
Estimated Year [2024]	USD 5.53 billion
Forecast Year [2030]	USD 9.33 billion
CAGR (%)	9.06%

Autoimmune Disease Diagnostics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Autoimmune Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autoimmune Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Autoimmune Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, AstraZeneca PLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited, bioMerieux SA, EUROIMMUN Medical Laboratory Diagnostics AG, Exagen Inc., F. Hoffmann-La Roche AG, Hemagen Diagnostics, Inc., Novartis AG, Pfizer Inc., Quest Diagnostics, Sanofi S.A., SD BioSensor Inc., Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and Werfen Group.

Market Segmentation & Coverage

This research report categorizes the Autoimmune Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Localized Autoimmune Disease Diagnostics
- Systemic Autoimmune Disease Diagnostics
Indication
- Addison Disease
- Celiac Disease
- Dermatomyositis
- Graves Disease
- Hashimoto Thyroiditis
- Multiple Sclerosis
- Myasthenia Gravis
- Pernicious Anemia
- Reactive Arthritis
- Rheumatoid Arthritis
- Sjogren syndrome
- Systemic Lupus Erythematosus
- Type I Diabetes
Test
- Autoantibodies & Immunologic Test
  - Anti-cyclic Citrullinated Peptide
  - Antinuclear Antibody
  - C-reactive Protein
  - Erythrocyte Sedimentation Rate
  - Rheumatoid Factor
  - Thyroid Antibody Tests
    - T3
    - T3RU
    - T4
    - TSH
- Inflammatory Marker
- Routine Laboratory Test
Product
- Consumable & Assay Kit
- Diagnostic Instrument
End User
- Clinical Laboratory
- Hospital
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Autoimmune Disease Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autoimmune Disease Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Autoimmune Disease Diagnostics Market?

4. What is the market share of the leading vendors in the Autoimmune Disease Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Autoimmune Disease Diagnostics Market?

Product Code: MRR-436901065F43

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Autoimmune Disease Diagnostics Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing Incidence of Autoimmune Diseases such as Rheumatoid Arthritis, Graves' disease and Hashimoto's thyroiditis
  - 5.1.1.2. Awareness Among Public About Autoimmune Diseases and Favorable Government Initiatives
  - 5.1.1.3. Improved Laboratory Techniques and Automation
- 5.1.2. Restraints
  - 5.1.2.1. High Frequency of False Positive Results
  - 5.1.2.2. Slow Turnaround Time for Diagnostic Test
- 5.1.3. Opportunities
  - 5.1.3.1. Adoption of Biosensors for Autoimmune Disease Diagnosis
  - 5.1.3.2. Strategic Partnerships Between Physicians and Clinical Laboratories
  - 5.1.3.3. Potential Growth in Reagent Rental Agreements and Collaboration Activities
- 5.1.4. Challenges
  - 5.1.4.1. Cost associated with the diagnosis process
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Autoimmune Disease Diagnostics Market, by Type

6.1. Introduction
6.2. Localized Autoimmune Disease Diagnostics
6.3. Systemic Autoimmune Disease Diagnostics

7. Autoimmune Disease Diagnostics Market, by Indication

7.1. Introduction
7.2. Addison Disease
7.3. Celiac Disease
7.4. Dermatomyositis
7.5. Graves Disease
7.6. Hashimoto Thyroiditis
7.7. Multiple Sclerosis
7.8. Myasthenia Gravis
7.9. Pernicious Anemia
7.10. Reactive Arthritis
7.11. Rheumatoid Arthritis
7.12. Sjogren syndrome
7.13. Systemic Lupus Erythematosus
7.14. Type I Diabetes

8. Autoimmune Disease Diagnostics Market, by Test

8.1. Introduction
8.2. Autoantibodies & Immunologic Test
- 8.3.1. Anti-cyclic Citrullinated Peptide
- 8.3.2. Antinuclear Antibody
- 8.3.3. C-reactive Protein
- 8.3.4. Erythrocyte Sedimentation Rate
- 8.3.5. Rheumatoid Factor
- 8.3.6. Thyroid Antibody Tests
  - 8.3.7.1. T3
  - 8.3.7.2. T3RU
  - 8.3.7.3. T4
  - 8.3.7.4. TSH
8.3. Inflammatory Marker
8.4. Routine Laboratory Test

9. Autoimmune Disease Diagnostics Market, by Product

9.1. Introduction
9.2. Consumable & Assay Kit
9.3. Diagnostic Instrument

10. Autoimmune Disease Diagnostics Market, by End User

10.1. Introduction
10.2. Clinical Laboratory
10.3. Hospital

11. Americas Autoimmune Disease Diagnostics Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Autoimmune Disease Diagnostics Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
- 15.1.1. Abbott Laboratories
- 15.1.2. AESKU.GROUP GmbH & Co. KG
- 15.1.3. AstraZeneca PLC
- 15.1.4. Beckman Coulter, Inc.
- 15.1.5. Bio-Rad Laboratories, Inc.
- 15.1.6. BioAgilytix Labs
- 15.1.7. Biogenuix Medsystems Private Limited
- 15.1.8. bioMerieux SA
- 15.1.9. EUROIMMUN Medical Laboratory Diagnostics AG
- 15.1.10. Exagen Inc.
- 15.1.11. F. Hoffmann-La Roche AG
- 15.1.12. Hemagen Diagnostics, Inc.
- 15.1.13. Novartis AG
- 15.1.14. Pfizer Inc.
- 15.1.15. Quest Diagnostics
- 15.1.16. Sanofi S.A.
- 15.1.17. SD BioSensor Inc.
- 15.1.18. Siemens Healthineers AG
- 15.1.19. SQI Diagnostics
- 15.1.20. Thermo Fisher Scientific Inc.
- 15.1.21. Trinity Biotech PLC
- 15.1.22. Werfen Group
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing